Dr. Reddy's Laboratories (RDY) News Today $14.26 -0.04 (-0.28%) (As of 11:52 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Dr. Reddy’s Boosts Workforce with Equity AllotmentDecember 3 at 5:37 AM | markets.businessinsider.comWhat is Zacks Research's Estimate for RDY FY2025 Earnings?November 29, 2024 | americanbankingnews.comDr. Reddy's Launches Toripalimab For Nasopharyngeal Carcinoma In IndiaNovember 28, 2024 | markets.businessinsider.comWhat is Zacks Research's Forecast for RDY FY2025 Earnings?Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Stock analysts at Zacks Research upped their FY2025 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research report issued on Tuesday, November 26th. Zacks Research analyst R. Department now expects that the companyNovember 28, 2024 | marketbeat.comDr. Reddy’s Fined in Germany for Registration LapseNovember 28, 2024 | markets.businessinsider.comDr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinomaNovember 28, 2024 | businesswire.comDr. Reddy’s and Senores launch Ivermectin tablets USP, 3 mg in U.S.November 26, 2024 | markets.businessinsider.comDr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US MarketNovember 26, 2024 | businesswire.comDr. Reddy’s Gains Strong Rating Amid Robust GrowthNovember 20, 2024 | markets.businessinsider.comDr. Reddy’s Laboratories Reports Record Quarterly GrowthNovember 13, 2024 | markets.businessinsider.comDr. Reddy's Laboratories (NYSE:RDY) Downgraded to Buy Rating by StockNews.comStockNews.com cut Dr. Reddy's Laboratories from a "strong-buy" rating to a "buy" rating in a report on Wednesday.November 13, 2024 | marketbeat.comDr. Reddy’s to Engage with Investors in MumbaiNovember 7, 2024 | markets.businessinsider.comBarclays Lowers Dr. Reddy's Laboratories (NYSE:RDY) Price Target to $17.00Barclays cut their target price on Dr. Reddy's Laboratories from $17.40 to $17.00 and set an "overweight" rating for the company in a research note on Wednesday.November 6, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (RDY) Q2 2025 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comIndia's Dr Reddy's Q2 profit drops on acquisition cost, impairment chargeNovember 5, 2024 | sg.finance.yahoo.comDr. Reddy's Lab Delivers 'Another Good Quarter,' CEO Says As Revenue Jumps 17%November 5, 2024 | benzinga.comDr. Reddy's Laboratories Limited 2025 Q2 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comDr. Reddy's Q2 & H1FY25 Financial ResultsNovember 5, 2024 | businesswire.comIndia's Dr Reddy's misses Q2 profit view on weak US demandNovember 5, 2024 | uk.finance.yahoo.comDr. Reddy's Laboratories rises Tuesday, still underperforms marketNovember 5, 2024 | marketwatch.comJourney gets FDA okay for Emrosi, releases preliminary Q3 earnings reportNovember 4, 2024 | msn.comDr. Reddy’s Announces New Employee Stock OptionsNovember 4, 2024 | markets.businessinsider.comJourney Medical announces U.S. FDA approval of EmrosiNovember 4, 2024 | markets.businessinsider.comDr. Reddy's Q2 2025 Earnings PreviewNovember 4, 2024 | msn.comDr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comDr. Reddy’s Launches Groundbreaking Drug in IndiaOctober 29, 2024 | markets.businessinsider.comDr. Reddy's Laboratories rises Monday, still underperforms marketOctober 28, 2024 | marketwatch.comJourney Medical announces presentation of DFD-29 dataOctober 26, 2024 | markets.businessinsider.comDr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive YearOctober 25, 2024 | businesswire.comDr. Reddy's Laboratories Stock Set to Split on Tuesday, November 5th (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) shares are scheduled to split before the market opens on Tuesday, November 5th. The 5-1 split was announced on Thursday, September 12th. The newly created shares will be payable to shareholders after the market closes on Monday, November 4th.October 24, 2024 | marketbeat.comZacks Research Has Optimistic Outlook of RDY Q2 EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research increased their Q2 2027 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research note issued to investors on Wednesday, October 16th. Zacks Research analyst R. Department now expects that the company wOctober 18, 2024 | marketbeat.comDr. Reddy's Laboratories outperforms market despite losses on the dayOctober 17, 2024 | marketwatch.comZacks Research Comments on Dr. Reddy's Laboratories Limited's Q2 2026 Earnings (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research boosted their Q2 2026 EPS estimates for shares of Dr. Reddy's Laboratories in a research report issued on Wednesday, October 16th. Zacks Research analyst R. Department now anticipates that the compaOctober 17, 2024 | marketbeat.comDr. Reddy's Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness MonthOctober 14, 2024 | businesswire.comArtemis Investment Management LLP Has $4.71 Million Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Artemis Investment Management LLP grew its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 280.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 59,306 shares of the coOctober 10, 2024 | marketbeat.comDr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy TrialOctober 9, 2024 | finance.yahoo.comAurigene Oncology Limited Announces Promising Results of Phase 1 Study for India's First Trial for Novel Autologous CAR-T Cell Therapy for Multiple MyelomaOctober 8, 2024 | businesswire.comDr. Reddy’s Unveils New Danish SubsidiaryOctober 8, 2024 | finance.yahoo.comSei Investments Co. Sells 26,041 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Sei Investments Co. lowered its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 66.8% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,935 shares of the company's stock after selling 26,041 shares during the qOctober 8, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Acquires 283,700 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 318.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 372,900 shOctober 4, 2024 | marketbeat.comCreative Planning Purchases 16,157 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Creative Planning increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 22.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 87,522 shares of the company's stock after buying anOctober 3, 2024 | marketbeat.comDr. Reddy’s Acquires Global NRT Leader NicotinellOctober 1, 2024 | finance.yahoo.comDimensional Fund Advisors LP Increases Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Dimensional Fund Advisors LP lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 12.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,003,782 shares of the company's stock afteSeptember 27, 2024 | marketbeat.comXTX Topco Ltd Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)XTX Topco Ltd acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,305 shares of the company's stock,September 24, 2024 | marketbeat.comAmerican Century Companies Inc. Has $11.19 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)American Century Companies Inc. grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 146,823 shares of the company's stock aSeptember 23, 2024 | marketbeat.com34,557 Shares in Dr. Reddy's Laboratories Limited (NYSE:RDY) Acquired by Frank Rimerman Advisors LLCFrank Rimerman Advisors LLC purchased a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 34,557 shares of the company's stSeptember 22, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) is Promethos Capital LLC's 7th Largest PositionPromethos Capital LLC boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 14.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,734 sharSeptember 20, 2024 | marketbeat.comIndian equity markets suffer losses amid increased selling pressureSeptember 20, 2024 | msn.comMondrian Investment Partners LTD Sells 22,329 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Mondrian Investment Partners LTD decreased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 13.6% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 142,218 shares of the company's stock after selling 22,329 shaSeptember 18, 2024 | marketbeat.comRenaissance Technologies LLC Purchases 65,606 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Renaissance Technologies LLC increased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 3.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,995,495 shares of the company's stock aftSeptember 16, 2024 | marketbeat.com Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crisis Could Be Worse Than 2008 (Ad)Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America is teetering on the edge of a collapse unlike anything we've seen. In my new book, "Midnight in America," I expose the hidden deals between Washington and Wall Street. RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.360.87▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼103▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News BioNTech News BeiGene News Teva Pharmaceutical Industries News Moderna News Viatris News Genmab A/S News Summit Therapeutics News Sarepta Therapeutics News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
